SuperworthSera Prognostics market cap SERA
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $80.1M
- Highest close in our data
- $351.8M
- May 2024
Sera Prognostics is worth $80.1M at the close on Oct 23, 2026, at $2.03 a share.
That is down 42% over the last year and down 74% over five years.
Its highest close in our data was $351.8M in May 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $80.1M | $67.4M | $142.4M | −41% |
| 2025 | $135.9M | $58.4M | $270.9M | −50% |
| 2024 | $270.2M | $166.1M | $351.8M | +44% |
| 2023 | $187.4M | $40M | $206.5M | +379% |
| 2022 | $39.1M | $36.9M | $245.6M | −81% |
| 2021 | $210.9M | $210.9M | $337.7M | n/a |
Against its peers
Companies in Healthcare nearest Sera Prognostics' size, closest first, today.
| Company | Market cap |
|---|---|
| SERASera Prognostics | $80.1M |
| LFVNLifevantage | $73.4M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| SPROSpero Therapeutics | $64.6M |
| APTAlpha Pro Tech | $56.7M |
| ATNMActinium Pharmaceuticals | $47.8M |
| NEPHNephros | $38.3M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $83.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Sera Prognostics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.